Canada Bio-Mfg Facility & COVID-19 reserved vaccines
Canada signs agreements with Pfizer, Novavax, J&J, & Moderna
- Pfizer, will supply a minimum of 20 million doses of its mRNA-based vaccine candidate, BNT162. Options for obtaining additional doses are under discussion.
- Johnson & Johnson, will supply up to 38 million doses of its vaccine candidate Ad26.COV2.S.
- Novavax, will supply up to 76 million doses of its vaccine candidate NVX-CoV2373.
- Moderna, will supply up to 56 million doses of its vaccine candidate mRNA-1273.
Minister: “Aggressive approach in procuring a portfolio of the most promising vaccine candidates”
According to the Minister of Public Services and Procurement, Anita Anand, “As we continue our work to purchase the supplies and equipment that are necessary to combat the COVID-19 pandemic, we remain equally focused on planning for the future, including securing potential vaccines for Canadians. We are taking an aggressive approach in procuring a portfolio of the most promising vaccine candidates in order to ensure that Canadians will have access to them as quickly as possible once they have been approved.”
Canada already has a $1 billion fund through the ‘Plan to Mobilize Science to fight COVID-19′ to develop a vaccine and treatments, as well as to track the virus. Of this fund, $600 million supports private sector work to develop a vaccine. See Canadian projects in chart below.
None of these vaccines have been approved as yet. They are in various stages of preliminary testing. See chart below.
According to a Canadian government statement, “Health Canada will review the evidence of safety, efficacy, and manufacturing quality for each vaccine to determine whether individual vaccines will be approved for use in Canada, before they are used to vaccinate Canadians.”
Read if you wish the standards testing should meet: COVID-19 vaccine trials should seek worthwhile efficacy Pub: 27 August 2020
Two Million Doses per Month Facility in Montreal at NRC
Canada will rapidly establish a new $126 million bio-manufacturing facility at the Human Health Therapeutics Research Centre (at NRC) in Montréal.
Through a public-private partnership, the new facility according to the Canadian government “will enable the National Research Council of Canada (NRC) to increase vaccine manufacturing to up to two million doses per month by next year”.
“Canada’s Current Status in the Fight Against COVID-19: Cases leveling, CFR Remains High,” says Civil Society biostatistician.
June 29, 2022
Population: 38,745,871 adjusted for estimated real COVID-19 deaths
|Reported:||3,948,186||41,896 1.06% CFR||3,852,879||53,411|
|Estimate:||21,833,469||54,464 *0.25% IFR||21,306,421||295,363|
*Inferred IFR is an estimate only. The actual COVID-19 IFR may not be accurately calculated for the entire human race until long after the pandemic has ended.
Recoveries are estimated using a Canadian-specific algorithm. Canadian COVID-19 Data is weekly by the country. Some data CSPAC obtains from Public Health Units is updated daily.
* Quebec, * Northwest Territories, * Prince Edward Island data is current daily.
Note: Last available First Nations data is shown when provided by the federal government of Canada.
Below: Extensive Estimates using data from multiple sources.
Beta experimental estimates for Canada. Reported + unreported mild + asymptomatic COVID-19 infections.
The total actual number of infections in Canada including all the untested, unreported, asymptomatic infections is likely greater than 21,833,469
(56.35% of the population) including mild and asymptomatic cases.
That would mean the estimated inferred average Infection Fatality Rate:
(IFR) is likely around 0.25%
Canadian COVID-19 deaths to 2022-06-29 are estimated to be 54,584 Using estimated IFR of 0.25% which is far below global average IFR.
54,584 (0.25% IFR) is the CSPaC estimated number of Canadian COVID-19 deaths (based on the inferred IFR) including those deaths unreported as COVID-19). The IHME estimates excess deaths in Canada to reach much higher than CSPaC estimates.
See The Lancet estimate of excess mortality from COVID-19 (Download PDF) in 191 countries/territories and 252 subnational units of select countries, from 1 January 2 0 2 0, to 31 December 2 0 2 1.
54464 Is the CSPaC estimated number of Canadian COVID-19 deaths based on a modified universal algorithm which factors more sophisticated public health infrastructure and also fewer available urgent care beds and facilities which is a problem in much of Canada in an emergency measures context.
The closeness of the two numbers derived from unique data and methods suggests their high probability. The blended data of three projections from three different biostatistician labs also confirms the estimates +/- .01%.
It is safe to say that Canadians have endured the grief of losing 54464 family members. Every number has a face. May their memory be forever a blessing to their families and friends.
Canada's advanced public health standards.
Ontario, Canada Reports
Ontario Regional Public Health Units (PHU) - Reported by Ontario Province.
These reports from the Ontario Provincial government differ significantly (much lower) from the data reported by individual Public Health Units (PHU). CSPaC includes links to each PHU to allow readers of this report to check the latest data from their public health unit.
|Haliburton Kawartha Pine Ridge||9,498||111||1.2%||9,332||55|
|Hastings & Prince Edward Counties||10,388||63||0.6%||10,254||71|
|Kingston Frontenac Lennox & Addington||17,560||60||0.3%||17,298||202|
|Leeds Grenville And Lanark District||9,567||106||1.1%||9,357||104|
|North Bay Parry Sound District||6,132||44||0.7%||6,037||51|
|Renfrew County And District||4,827||50||1.0%||4,744||33|
|Simcoe Muskoka District||46,634||438||0.9%||45,927||269|
|Sudbury And District||15,522||150||1.0%||15,240||132|
|Thunder Bay District||12,907||96||0.7%||12,640||171|
Justin Trudeau, Prime Minister of Canada said Monday that, “As we continue to work together to limit the impact of the COVID-19 pandemic on the health of Canadians, as well as its social and economic effects, we must also maximize our chances of defeating the virus. To do this, we need to invest in the development of several promising vaccines and ensure that we can manufacture and distribute the vaccine to as many Canadians as possible, as quickly as possible. That is how we will move forward on a sustainable path to a full recovery.”
Watch Patty Hajdu, Minister of Health.
Chart: SARS2-CoV-2 vaccine candidates in Phase 1-3 plus significant candidates in pre-clinical R&D
Chart Data Source: Regulatory Affairs Professionals Society.
“Do Minions Catch The Virus?” asked the nurse at a remote clinic while speaking to some children. “Not if they do these simple things,” she went on. Hey kids. Funny Minions, silly Gru, some moms, doctors and nurses explain social